PHACTS: Why Would A New Zealand-Based Non-Government Organisation Use Precious Resources To Develop A Database Application?
Wise Management Services, Adobe Acrobat format.
Wednesday, August 04, 2004
Eli Lilly Wins US Approval for New Depression Drug`
Brief Reuters Health story at Medscape - "Eli Lilly & Co. on Wednesday said U.S. regulators have approved its new antidepressant, Cymbalta (duloxetine). The U.S. Food and Drug Administration said the drug is both safe and effective in treating major depression, the company reported in a statement. Cymbalta is a serotonin and norepinephrine reuptake inhibitor. In this respect, it is similar to Wyeth's Effexor XR, rather than SSRIs such as Lilly's Prozac..." [Viewing Medscape resources requires registration, which is free].
comment []
Brief Reuters Health story at Medscape - "Eli Lilly & Co. on Wednesday said U.S. regulators have approved its new antidepressant, Cymbalta (duloxetine). The U.S. Food and Drug Administration said the drug is both safe and effective in treating major depression, the company reported in a statement. Cymbalta is a serotonin and norepinephrine reuptake inhibitor. In this respect, it is similar to Wyeth's Effexor XR, rather than SSRIs such as Lilly's Prozac..." [Viewing Medscape resources requires registration, which is free].
comment []
Atypical Antipsychotics Increasingly Used in Children
Reuters Health story at Medscape - "Atypical antipsychotic drugs are increasingly being prescribed for children with attention deficit/hyperactivity disorder (ADHD) and affective disorders, investigators report. However, there is little evidence that the benefits of treatment outweigh the risk. Dr. William O. Cooper and associates at Vanderbilt University in Nashville, Tennessee, reviewed medical records of children enrolled between 1996 and 2001 in Tennessee's expanded Medicaid program to identify new users of atypical antipsychotics, such as risperidone and olanzapine. During this period, 6803 children became new users, approximately doubling from 23 per 10,000 in 1996 to 45 per 10,000 in 2001." [Viewing Medscape resources requires registration, which is free].
comment []
Reuters Health story at Medscape - "Atypical antipsychotic drugs are increasingly being prescribed for children with attention deficit/hyperactivity disorder (ADHD) and affective disorders, investigators report. However, there is little evidence that the benefits of treatment outweigh the risk. Dr. William O. Cooper and associates at Vanderbilt University in Nashville, Tennessee, reviewed medical records of children enrolled between 1996 and 2001 in Tennessee's expanded Medicaid program to identify new users of atypical antipsychotics, such as risperidone and olanzapine. During this period, 6803 children became new users, approximately doubling from 23 per 10,000 in 1996 to 45 per 10,000 in 2001." [Viewing Medscape resources requires registration, which is free].
comment []
Patient safety programme to safeguard mental health service users UK
Medical News Today story - "A project to improve the safety of mental health service users by creating a safer environment on acute psychiatric wards was announced today by the National Patient Safety Agency (NPSA). This is the first project in an extensive programme of work developed by the NPSA to ensure that services for people with mental ill-health in England and Wales are provided in the safest way possible..."
comment []
Medical News Today story - "A project to improve the safety of mental health service users by creating a safer environment on acute psychiatric wards was announced today by the National Patient Safety Agency (NPSA). This is the first project in an extensive programme of work developed by the NPSA to ensure that services for people with mental ill-health in England and Wales are provided in the safest way possible..."
comment []
Patients kept in dark about care (UK)
BBC story - "Many NHS patients say they are not involved enough in decisions about their care, a survey reveals. The Healthcare Commission quizzed 300,000 patients and found most wanted more input into their care, especially those with a mental illness. Of 27,000 people using mental health services, 15% said they did not have enough say in care decisions and 44% only had a say to some extent. Nearly a fifth said their diagnosis had not been discussed with them..."
comment []
BBC story - "Many NHS patients say they are not involved enough in decisions about their care, a survey reveals. The Healthcare Commission quizzed 300,000 patients and found most wanted more input into their care, especially those with a mental illness. Of 27,000 people using mental health services, 15% said they did not have enough say in care decisions and 44% only had a say to some extent. Nearly a fifth said their diagnosis had not been discussed with them..."
comment []
Copyright 2003 © Bill Davis.
IIMHL Update is a project done in collaboration with MHCA and the Centre for Community Change International. IIMHL Update is powered by Radio Userland.